Topotecan Hydrochloride

規格

119413-54-6CAS番号

601-607-9EC番号

(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;hydrochlorideIUPAC名

C23H24ClN3O5化学式

457.9 g/mol分子量

TOPOTECAN HYDROCHLORIDE; 119413-54-6; Topotecan Hcl; Nogitecan hydrochloride; Evotopin; Topotecan teva; Topotecan Actavis; Topotecan Hospira; SK&F S-104864-A; potactasol; DTXSID1045952; SK&F-S-104864-A; Topotecan (as hydrochloride); NSC-759263; 956S425ZCY; DTXCID9025952; SK-S-104864-A; Hydrochloride, Nogitecan; Hydrochloride, Topotecan; RefChem:57198; topotecan hydrochloride (oral); Topotecan Monohydrochloride, (S)-; SKF S-104864-A; (S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7) indolizino(1,2-b) quinoline-3,14-(4H,12H)-dione Monohydrochloride; Hycamtin; Topotecan (Hydrochloride); Topotecan monohydrochloride; Topotecan hydrochloride [USAN]; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[l,2-b]quinoline-3,14(4H,12H)-dione monohydrochloride; MFCD00866235; C23H24ClN3O5; SKF-104864A; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione monohydrochloride; (S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; NCGC00095189-01; Hycamtin (TN); SKF 104864A; NSC 609669; 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-, monohydrochloride, (S)-; Nogitecan hydrochloride (JAN); Topotecan hydrochloride (USAN); SKF 104864A (Hydrochloride);NSC 609669 (Hydrochloride); CHEMBL1607; Hycamptamine hydrochloride; NOGITECAN HYDROCHLORIDE [JAN]; (19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;hydrochloride; (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione hydrochloride; 1067286-75-2; SMR000466344; CAS-119413-54-6; SK&F-S-104864A; DRG-0288; 1,4-Di[4-(3-phenoxypropoxy)-2-butynyl]piperazine; Evotropin; UNII-956S425ZCY; s1231; Potactasol (TN); SKF 104864A; Topotecan Hydrocholoride; SCHEMBL7247; SCHEMBL7248; Hycamtin (TN) (GlaxoSmith); MLS000759456; MLS001401447; SPECTRUM1505820; orb1183600; orb1226834; orb1309516; SCHEMBL29375999; CHEBI:232548; GLXC-05536; HMS1922H22; HY-13768AR; MSK157243A; Pharmakon1600-01505820; SKF-S 104864-A; TOPOTECAN HYDROCHLORIDE [MI]; Tox21_111478; CCG-37460; EBC-11244; HY-13768A; NCGC00014925; NCI609699; NK-211; NSC759263; Topotecan (hydrochloride) (Standard); AKOS015900415; Tox21_111478_1; AC-1551; CS-1498; FT28329; KS-1410; NC00177; NSC 759263; NSC-609669; TOPOTECAN HYDROCHLORIDE [MART.]; TOPOTECAN HYDROCHLORIDE [VANDF]; TOPOTECAN HYDROCHLORIDE [USP-RS]; TOPOTECAN HYDROCHLORIDE [WHO-DD]; NCGC00014925-06; NCGC00095189-02; NCGC00095189-03; SY013198; SW197557-5; TOPOTECAN HYDROCHLORIDE [ORANGE BOOK]; D02168; E-89/001; 9-Dimethylaminomethyl-10-hydroxycamptothecin, HCl salt; Q27271753; 9-[(DIMETHYLAMINO)METHYL]-10-HYDROXY-(20S)-CAMPTOTHECIN, HCL; (4S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4',6-7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONE; (4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4',6-7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochlorid e; (4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione--hydrogen chloride (1/1); (4S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONEHYDROCHLORIDE (1:1); (S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dionehydrochloride; (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-Pyrano[3 inverted exclamation mark ,4 inverted exclamation mark :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione Hydrochloride; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONEMONOHYDROCHLORIDE; 10-[(Dimethylamino)methyl]-4S-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, HCl; 1H-Pyrano[3',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, monohydrochloride, (4S)-別名